Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
INACTIVE COMPANY
 
My Lists

Cellective Dx

265 N Whisman Road
Mountain View, CA 94043
USA
650 938 9800
Website Company Summary Management Team
Team

Management: Michael Grisham (CEO);  Anne R. Kopf-Sill (President);  Jeanne Harvey (VP Biology & Chemistry);  Lee Aurich (CFO)
Outside board: William Ericson (Mohr Davidow Ventures) Susan E. Siegel (Mohr, Davidow Ventures)
Company

Business description: CELLective Dx is an early-stage company developing a new generation of diagnostic tools for cancer based on analysis of CTCs directly from a patient’s blood. Our novel proprietary technologies combine microfluidics, flow dynamics, cell biology, molecular biology, biochemistry, and surface chemistry to capture and analyze rare CTCs in blood more rapidly and effectively than other current technologies. CELLective Dx is developing simple, rapid, blood-based cancer tests that will provide physicians and patients with accurate and individualized clinical information on disease status, treatment selection, and treatment response that will dramatically improve the clinical management of cancer.
Capital

Rounds: 2
Recent fundings: Oct 2008   Aug 2007
Capital raised: 25.0M
Last Round: 5.0M
Ownership: Private  

Last Tweets


 

Last Mentions


Overview
Record updated: Oct 2008
Sector: Medical
Year Founded: 2005
Rounds: 2
Recent fundings: Oct 2008   Aug 2007
Capital raised: 25.0M
Last Round: 5.0M
Ownership: Private